Bayer Schering ties-up with AC Immune for trial in Alzheimer´s disease
Saturday, October 10, 2009 12:00 IST Berlin, Germany
Bayer Schering Pharma AG, Germany, will provide its development candidate florbetaben, a so called PET (positron emission tomography) tracer, to the Swiss-based biopharmaceutical company AC Immune SA